Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.6 |
mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.6 |
mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |